𝐒𝐞𝐞𝐤𝐢𝐧𝐠𝐒𝐞𝐫𝐞𝐧𝐢𝐭𝐲(@PsychNurseLee) 's Twitter Profile Photo

A 1 month supply (4 syringes)of $REGN ‘s cost $7200.
Insurance pays $4200.
Thank God REGN has co-pay assistance that covers the balance or I would’ve had to donate a kidney,sell my house or resort to the worlds oldest profession. Anything for my son!

A 1 month supply (4 syringes)of $REGN ‘s #monoclonalantibody #Dupixent cost $7200.
Insurance pays $4200.
Thank God REGN has co-pay assistance that covers the balance or I would’ve had to donate a kidney,sell my house or resort to the worlds oldest profession. Anything for my son!
account_circle
Wertheim UF Scripps(@UFScripps) 's Twitter Profile Photo

Neutralizing a master regulator of inflammation could protect women facing preterm birth, as well as the health of their babies, a new study from Wertheim UF Scripps suggests. 1/4
scripps.ufl.edu/2023/06/22/inf…

NIH NIDDK

account_circle
Genetic Engineering & Biotechnology News(@GENbio) 's Twitter Profile Photo

Revolutionizing Monoclonal Antibody Production Monitoring

Swedish researchers have developed a microfluidic chip that they hope will allow for easier monitoring of ( ) production. Learn more: ow.ly/y7u250NRpCw

Revolutionizing Monoclonal Antibody Production Monitoring

Swedish researchers have developed a microfluidic chip that they hope will allow for easier monitoring of #monoclonalantibody (#mAb) production. Learn more: ow.ly/y7u250NRpCw
account_circle
Immunotherapy Advances Journal(@IMTadvances) 's Twitter Profile Photo

In this 1st in-human trial for , Ashish Marwaha BMBCh, MA, PhD, FABMGG,FCCMG, FRCPC et al. assessed the safety & immune mechanism of ustekinumab, a used in psoriasis targeting the IL-12 & IL-23 pathways

💡 An interesting read for : bit.ly/466OtoJ

In this 1st in-human #immunotherapy trial for #type1diabetes, @DrAshM2 et al. assessed the safety & immune mechanism of ustekinumab, a #MonoclonalAntibody used in psoriasis targeting the IL-12 & IL-23 pathways  

💡 An interesting read for #DiabetesWeek: bit.ly/466OtoJ
account_circle
ACF Equity Research(@ACFER01) 's Twitter Profile Photo

$ZVSA combating inflammation to treat Alzheimer's et al - dvlps IC 100 - targets inflammasome ASC specks (great therapeutic potential - as per 's & Dementia journal). Global AD drug mkt @ ~US$ 3,1bn by 2028E. Read our

$ZVSA combating inflammation to treat Alzheimer's et al - dvlps #monoclonalantibody IC 100 - targets inflammasome ASC specks (great therapeutic potential - as per #Alzheimer's & Dementia journal). Global AD drug mkt @ ~US$ 3,1bn by 2028E. Read our #ACFInsight…
account_circle
a tired human(@saffronandsky) 's Twitter Profile Photo

Are there any more reports from people in the for trial? I need some good news? Things seem to be getting worse and worse over here, hovering at the edge of very severe (looking at phone makes me shake). Just need some hopeful news.

account_circle
IJMSC(@IJMSCtweets) 's Twitter Profile Photo

Network meta-analysis synthesis of current treatments for relapsing , including recently introduced DMTs. therapies most efficacious; & in top 3 most efficacious for reducing ARR & delaying⏰to 3mCDP & 6mCDP. doi.org/10.57264/cer-2…

Network meta-analysis synthesis of current treatments for relapsing #MS, including recently introduced DMTs. #MonoclonalAntibody therapies most efficacious; #alemtuzumab & #ofatumumab in top 3 most efficacious for reducing ARR & delaying⏰to 3mCDP & 6mCDP. doi.org/10.57264/cer-2…
account_circle
ARDİ 🇹🇷(@ARDiARASTIRMA) 's Twitter Profile Photo

⚡Anti-Human CD86 Monoclonal Antibody APC Conjugated, Flow Validated

💫SKU:FC00220-APC
💫Boyut: 100 test, 200 test
💫Reaktif Türler: Cynomolgus maymunu, İnsan, Babun, Rhesus maymunu
💫Konak: Fare
💫Uygulama: Flow Sitometrisi

⚡Anti-Human CD86 Monoclonal Antibody APC Conjugated, Flow Validated

💫SKU:FC00220-APC
💫Boyut: 100 test, 200 test
💫Reaktif Türler: Cynomolgus maymunu, İnsan, Babun, Rhesus maymunu
💫Konak: Fare
💫Uygulama: Flow Sitometrisi

#monoclonalantibody
account_circle
Lisa Martin, PhD(@LJM2344) 's Twitter Profile Photo

Our recent clinical trial shows that using Benralizumab for eosinophilic gastritis can eliminate tissue eosinophilia but may not impact other features of the disease. Link good til 8/5/2023
authors.elsevier.com/c/1hGF58nByr8t…

account_circle
TRAstonDrs(@CastlTrAstonDrs) 's Twitter Profile Photo

nature therapy & vaccination For provide similar protection at equivalent neutralizing antibody titers is consistent. Multiple monoclonal antibody products have been shown to be effective as pre- &…

#IDtwitter #Immunology #Viralimmunology @Nature #monoclonalantibody therapy & vaccination For #COVID19 provide similar protection at equivalent neutralizing antibody titers is consistent. Multiple monoclonal antibody products have been shown to be effective as pre- &…
account_circle